Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay
Several programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays have been developed independently within clinical programs for therapeutic anti-programmed cell death protein 1 (anti-PD-1) or PD-L1 antibodies, necessitating assessment of assay comparability. We characterized the Dako PD-L...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2020
|
| 在线阅读: | https://doi.org/10.1016/j.jtho.2020.04.013 http://www.jto.org/article/S1556086420303270/pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|